产品详情
靶点信息
IGF-1R | ||||
0.17 μM |
In vitro | DMSO | Warmed: 9 mg/mL (19.84 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (6.61 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.05 mL | 110.23 mL | 220.46 mL |
0.5 mM | 4.41 mL | 22.05 mL | 44.09 mL |
1 mM | 2.2 mL | 11.02 mL | 22.05 mL |
5 mM | 0.44 mL | 2.2 mL | 4.41 mL |
*The above data is based on the productmolecular weight 453.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10658 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 453.6 |
Formula | C28H31N5O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 475488-23-4 |
Synonyms | NVPADW742, ADW742, ADW-742, GSK 552602A |
SMILES | C1CCN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6 |
产品标签
Product Questions
Product Questions
GSK1904529A
GSK1904529A分别用27和25 nmol/L的IC(50)s选择性抑制IGF-IR和IR。
BMS-536924
BMS-536924是有效的IGF-IR抑制剂,可导致IGF-IR介导的转化表型逆转。
NVP-AEW541
NVP-AEW541是一种选择性的IGF-1R激酶抑制剂,可抑制IGF-1R的自磷酸化活性(IC50 = 0.086 uM)并阻止IGF-1介导的MCF-7…
Picropodophyllin
Picropodophyllin是首个靶向口服小分子igf-1受体抑制剂,IC50为1 nM。对胰岛素受体无影响。
AG-1024 (Tyrphostin)
AG-1024 (Tyrphostin)是胰岛素样生长因子-1 (IGF-1) 和胰岛素受体酪氨酸激酶活性的特异性抑制剂。与胰岛素受体…
BMS-754807
BMS-754807是一种有效的,口服活性生长因子1受体/胰岛素受体家族靶向的激酶抑制剂。